Drug Testing Flashcards

1
Q

What are the 2 types of gating in ion channels?

A
  1. Ligand gating
  2. Voltage gating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do ligand gating ions channels work?

A

The binding ligand induces change in the channel’s shape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do voltage gating ions channels work?

A

Change in ion concentration triggers opening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a full agonist?

A

Molecules which mimic the effects of a ligand, achieve up to the same mazimum effect as a ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a partial agonist?

A

Do not achieve 100% effect of a ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the leaky receptors?

A

Receptors which trigger an activity even when nothing is bound to them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are inverse agonists?

A

Switch off the natural activity of leaky receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are antagonists?

A

Competes with the natural ligand, so it can’t bind to the cite to activate the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define Affinity

A

How strongly the ligand/drug binds to receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can affinity be tested?

A

Using radiolabelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does the value of KD mean

A

Concentration at which 50% of the receptors are occupied

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define efficacy

A

Measure of the maximum bological effect that a drug can produce as a result of binding to the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define potency

A

A measure of the concentration of a drug to cause a specific effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is potency of antagonist determined?

A

By measuring agonist efficacy in the presence of different antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define Desensitisaiton

Eg opioid abuse

2 points

A
  • Agonist that bind strongly to a receptor switch it on, but then may block the receptor for a long period of time.
  • They are acting as agonists and then antagonists.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define Sensitisation

Giving beta blockers for a prolonged period of time

2 points

A
  • Antagonists tend to be slow to add and slow to leave
  • The cell synthesises more receptors to compensate for the receptors that are blocked.
17
Q

What is Lipinski rule of 5?

A
  1. Molecular weight < 500
  2. HBD max 5
  3. HBA max 10
  4. log P < 5
18
Q

What is Verber’s rule?

A

Rotatable bonds < 10

19
Q

What is eflux?

A

Process of removing waster from the brain

20
Q

3 ways of transporting a drug to the brain

A
  1. Passive diffusion
  2. Active transport (attaching to a transport protein)
  3. Receptor-mediated transcytosis
21
Q

What is Receptor-mediated transcytosis?

A

Receptor attaches to a molecule and travels with the molecule through BBB

22
Q

What is free drug hypothesis?

A

Free drug concentration at the cite of action is responsible for pharmacological activity in vivo and at steady state and in the absence of active transport the free drug concentration is the same on both sides of any biomembrane (except BBB)

23
Q

What drugs for CNS need special consideration of lipophilicity?

A

Lipophilicity helps CNS penetration but too much will result in a high efflux

24
Q

What is the rule of 4?

A
  • Compounds of Mr < 400
  • Total number of N and O atoms < 4
  • Basic pKa < 8
  • Those are unlikely to be P-gp substrates
25
Q

How does H-bonding affect drugs accessing CNS?

3 points

A
  • H bondng = lower Kp
  • Lower rate of permeation: poorer lipid solubility, increased P-gp binding
  • Lower K_{p,uu}
26
Q

2 main stategies in antagonist design

A
  1. Design a drug that is the right shape & main interactions to bind to the receptor binding site - prevents binding of agonist
  2. Make new interactions with different parts of the binding site that are not used by the agonist
27
Q

What do protein kinases do?

A

Catalyse the transfer of phosphate group from ATP to a specific molecule